Maria del Valle Morales

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The outcome of patients with acute venous thromboembolism (VTE) and abnormal platelet count (PlC) at baseline has not been consistently studied. In real-world clinical practice, a number of patients with abnormal PlC receive vitamin K antagonists (VKAs) to treat acute VTE despite their higher risk of bleeding.We used the Registro Informatizado de Enfermedad(More)
  • 1